Meet Trump’s pick to regulate your food and medicine

美债40万亿!新财长紧急出手救市!

Apple News Today

2026-08-20

15 分钟
PDF

单集简介 ...

President Trump nominated White House aide Dr. Heidi Overton to lead the FDA, which has lacked a permanent leader for months. The Washington Post’s Rachel Roubein explains why some senators are already raising doubts. Trump paused steep tariffs on Canadian imports hours before they were set to take effect. The Wall Street Journal’s Gavin Bade breaks down what happened. The U.S. is casting a shadow over Brazil’s presidential race. Reuters’s Manuela Andreoni discusses how incumbent Luiz Inácio Lula da Silva and Trump ally Flávio Bolsonaro are gearing up for a tight contest. Plus, U.S. national public debt topped $40 trillion for the first time, Prince Harry and Meghan Markle are moving back to the U.K., and how a goose’s honks saved a Texas family’s barn from burning down. Today’s episode was hosted by Cecilia Lei.
更多

单集文稿 ...

  • Good morning.

  • President Trump reveals his pick to lead the country's Food and Drug Administration.

  • The US touts a major deal with Canada as it reverses course on steep tariffs.

  • And in Brazil's upcoming elections,

  • Bolsonaro's son looks to take center stage with the help of the White House.

  • "It's going to be a big test of the United States' power and influence over the region."

  • It's Thursday, August 20th.

  • I'm Cecilia Lei, in for Shumita Basu.

  • This is Apple News Today.

  • The Trump administration has nominated a White House aide to run the FDA,

  • a regulator that hasn't had a permanent leader in months.

  • But it's already looking like she might have a tough time getting confirmed.

  • Dr. Heidi Overton is a deputy assistant to the president with a focus on health issues.

  • In a social media post, Trump described her as a "rock star" and suggested

  • that she had the full support of Health and Human Services Secretary Robert F. Kennedy Jr.

  • Trump's former FDA commissioner, Marty Makary, resigned in May after clashes with staff and biotech companies.

  • A wave of other senior figures followed,

  • leaving the FDA in a state of flux and looking for new leadership.

  • Rachel Roubein is a health reporter for The Washington Post.

  • "It's a hugely important role.